XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Net loss $ (51,181,000) $ (44,731,000) $ (44,675,000)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation 856,000 1,062,000 1,149,000
Stock-based compensation 7,397,000 6,111,000 4,890,000
Amortization of premiums (accretion of discounts) on short-term investments 85,000 (29,000) (787,000)
Amortization of debt discount 172,000 191,000 189,000
Impairment of property and equipment 727,000 0 0
Changes in operating assets and liabilities:      
Prepaid and other assets (1,564,000) 108,000 536,000
Accounts payable 276,000 (374,000) 127,000
Accrued expenses 1,459,000 (2,419,000) 1,656,000
Accrued compensation (477,000) 1,334,000 (42,000)
Right-of-use assets and lease liabilities, net (168,000) (127,000) 32,000
Net cash used in operating activities (42,418,000) (38,874,000) (36,925,000)
Cash flows from investing activities:      
Purchases of short-term investments 0 (68,581,000) (85,004,000)
Maturities of short-term investments 55,490,000 48,500,000 114,000,000
Purchases of property and equipment (295,000) (134,000) (700,000)
Proceeds from disposition 768,000 0  
Net cash provided by (used in) investing activities 55,963,000 (20,215,000) 28,296,000
Cash flows from financing activities:      
Proceeds from issuance of common stock and pre-funded warrants, net of issuance costs 32,207,000 64,187,000  
Proceeds from issuance of long-term debt, net of cash issuance costs 674,000    
Proceeds from short-term debt   1,126,000  
Principal payments on short-term debt   (1,126,000)  
Proceeds from issuance of common stock under employee stock purchase plan 213,000 270,000 242,000
Proceeds from exercise of stock options 6,000 206,000 5,000
Payments of debt issuance costs     (52,000)
Net cash provided by financing activities 33,100,000 64,663,000 195,000
Net change in cash, cash equivalents and restricted cash 46,645,000 5,574,000 (8,434,000)
Cash, cash equivalents and restricted cash at beginning of period 31,469,000 25,895,000 34,329,000
Cash, cash equivalents and restricted cash at end of period 78,114,000 31,469,000 25,895,000
Cash and cash equivalents at end of period 77,412,000 30,767,000 25,194,000
Restricted cash at end of period 702,000 702,000 701,000
Supplemental cash flow information:      
Cash paid for interest 1,422,000 1,373,000 1,394,000
Supplemental disclosure of non-cash investing and financing activities:      
Purchase of property and equipment in accounts payable and accrued expenses $ 85,000 $ 67,000 $ 76,000